Dr. Hoppe and colleagues present a strong case supporting the use of proton therapy (PT) for the treatment of patients with Hodgkin lymphoma (HL).
Richard J. Bram, MD, PhD
Advertisement
Articles by Richard J. Bram, MD, PhD
Advertisement
- Adverse Effects
- Artificial Intelligence
- Brain Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Genitourinary Cancers
- Gynecologic Cancers
- Head & Neck Cancer
- Hematologic Oncology
- Infection
- Leukemia
- Lung Cancer
- Lymphoma
- Neuroendocrine Tumors
- Oncology
- Pediatric Cancers
- Psycho-Oncology
- Radiation Oncology
- Sarcoma
- Screening
- Skin Cancer & Melanoma
- Surgery
- Thyroid Cancer